Adenosine triphosphate

Sinopharm (Guangzhou) International Co., Ltd., founded in 1993, is a wholly-owned subsidiary of China International Medical and Health Co., Ltd (Sinopharm). Sinopharm is the largest comphehensive medical and health group in China. The group with its subsidiary companies have business in production and manufacture, distribution and logistic and international trading of human vaccines, immunoglobulin, pharmaceutical and medicines, pharmaceutical intermediates and APIs, medical consumable and devices, laboratory equipment and consumables. In 2021, the yearly revenue of Sinopharm Group exceeded 700 billion yuan, and its total profit exceeded 100 billion yuan. Sinopharm Group is ranked 80 in the Fortune 500 and 1st in the list of the world's top 100 pharmaceutical enterprises. Sinopharm Group has 1700 subsidiaries and 8 listed companies, with a total of 210,000 employees.